Insider Transactions in Q3 2023 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,163
-4.22%
|
$84,357
$39.67 P/Share
|
|
Sep 07
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.2%
|
$42,000
$21.0 P/Share
|
|
Sep 05
2023
|
Erik Harris EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-10.47%
|
$222,000
$37.96 P/Share
|
|
Sep 01
2023
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
970
-1.97%
|
$35,890
$37.64 P/Share
|